A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris
Public ClinicalTrials.gov record NCT02395549. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is designed to investigate the efficacy, safety and tolerability of MTC896 Gel in subjects with acne. In this study, MTC896 Gel will be applied at 3 concentrations, twice daily (bid) for 12 weeks and compared against a vehicle control.
Study identification
- NCT ID
- NCT02395549
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 364 participants
Conditions and interventions
Conditions
Interventions
- 0.375% (w/w) MTC896 Gel Drug
- 0.75% (w/w) MTC896 Gel Drug
- 1.5% (w/w) MTC896 Gel Drug
- Vehicle Control Gel Drug
Drug
Eligibility (public fields only)
- Age range
- 16 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2015 (Type not available)
- Primary completion
- Jun 2016 (Actual)
- Completion
- Aug 2016 (Estimated)
- Last update posted
- Jun 16, 2016
2015 – 2016
United States locations
- U.S. sites
- 20
- U.S. states
- 14
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Sacramento | California | — | — |
| Not listed | San Diego | California | 92108 | — |
| Not listed | San Diego | California | 92123 | — |
| Not listed | Denver | Colorado | — | — |
| Not listed | Sanford | Florida | — | — |
| Not listed | West Palm Beach | Florida | — | — |
| Not listed | Louisville | Kentucky | — | — |
| Not listed | Warren | Michigan | — | — |
| Not listed | Minneapolis | Minnesota | — | — |
| Not listed | Albuquerque | New Mexico | — | — |
| Not listed | High Point | North Carolina | — | — |
| Not listed | Hershey | Pennsylvania | — | — |
| Not listed | Johnston | Rhode Island | — | — |
| Not listed | Warwick | Rhode Island | — | — |
| Not listed | Nashville | Tennessee | — | — |
| Not listed | Austin | Texas | — | — |
| Not listed | College Station | Texas | — | — |
| Not listed | Plano | Texas | — | — |
| Not listed | Salt Lake City | Utah | — | — |
| Not listed | Spokane | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02395549, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 16, 2016 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02395549 live on ClinicalTrials.gov.